# Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-nivolumab-or-nivolumab-plus-ipilimumab-in-operable-non-small-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tina Cascone,William N. William,Annikka Weissferdt,Cheuk Hong Leung,Heather Lin,Apar Pataer,Myrna C. B. Godoy,Brett W. Carter,Lorenzo Federico,Alexandre Reuben,M.A. Wadud Khan,Hitoshi Dejima,Alejandro Francisco‐Cruz,Edwin R. Parra,Luisa M. Solis,Junya Fujimoto,Hai T. Tran,Neda Kalhor,Frank V. Fossella,Frank E. Mott,Anne S. Tsao,George Blumenschein,Xiuning Le,Jianjun Zhang,Ferdinandos Skoulidis,Jonathan M. Kurie,Mehmet Altan,Charles Lu,Bonnie S. Glisson,Lauren A. Byers,Yasir Y. Elamin,Reza J. Mehran,David C. Rice,Garrett L. Walsh,Wayne L. Hofstetter,Jack A. Roth,Mara B. Antonoff,Humam Kadara,Cara Haymaker,Chantale Bernatchez,Nadim J. Ajami,Robert R. Jenq,Padmanee Sharma,James P. Allison,P. Andrew Futreal,Jennifer A. Wargo,Ignacio I. Wistuba,Stephen G. Swisher,J. Jack Lee,Don L. Gibbons,Ara A. Vaporciyan,John V. Heymach,Boris Sepesi |
| Citations | 613 |
| DOI | 10.1038/s41591-020-01224-2 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/8818318 |
| OpenAlex ID | https://openalex.org/W3132841322 |
| PMID | 33603241 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Tina Cascone](https://scholariq.org/researchers/tina-cascone/)
- [Xiuning Le](https://scholariq.org/researchers/xiuning-le/)
- [John V. Heymach](https://scholariq.org/researchers/john-v-heymach/)
- [Lauren A. Byers](https://scholariq.org/researchers/lauren-a-byers/)
- [Jianjun Zhang](https://scholariq.org/researchers/jianjun-zhang-2/)
- [Bonnie S. Glisson](https://scholariq.org/researchers/bonnie-s-glisson/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.